On September 11, 2020 BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, reported that Todd Norbe, President and Chief Executive Officer and John Beaver, Chief Operating Officer and Chief Financial Officer, will be providing an overview of the Company, as well as recent progress and achievements at the H.C. Wainwright 22nd Annual Global Investor Conference on Wednesday, September 16, 2020 at 11:00 am Pacific Time (2:00 pm ET) (Press release, Biolase Technology, SEP 11, 2020, View Source [SID1234565042]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The conference will feature virtual one-on-one meetings with the BIOLASE’ executives and institutional investors are invited to request meeting times at [email protected] or through their H.C. Wainwright representative. The formal presentation will be webcast live and will be available for replay at View Source or in the investor relations section of BIOLASE’s website at www.biolase.com.